A Comprehensive Expert Overview

Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition affecting the brain’s ability to regulate attention, behaviour, and emotional responses. Historically, ADHD has been portrayed through the behaviour of young boys - hyperactive, distractible, and impulsive. This narrow understanding has contributed to decades of under-recognition of ADHD in girls and women.

Across Aotearoa New Zealand, a growing number of women are only now receiving diagnoses in adulthood. For many, the journey to diagnosis follows years of unexplained difficulty, self-blame, inconsistent academic or occupational performance, and mental health challenges that were treated without addressing the underlying condition.

This article explores the unique presentation of ADHD in women, why so many remain undiagnosed, and the specific challenges within the New Zealand healthcare system.
ADHD in Females: A Different Presentation

ADHD symptoms fall into two main categories: inattention and hyperactivity/impulsivity. While males are more likely to present with hyperactive or combined-type ADHD, women are disproportionately represented in the predominantly inattentive presentation - previously labelled ADD.

Because inattentive symptoms are subtle, internalised, and non-disruptive, they are easy to overlook.

Common symptoms in females include:

Frequent daydreaming or appearing mentally absent
Difficulty sustaining attention, especially with complex or lengthy tasks
Chronic disorganisation and struggles with time management
Forgetfulness in daily routines, appointments, and responsibilities
Mental fatigue from constant cognitive overload
Avoidance of tasks requiring prolonged effort

These behaviours are often misinterpreted as a lack of discipline, poor motivation, personality quirks, or emotional sensitivity. As a result, girls grow into women who feel “different” but cannot identify why everyday tasks seem harder for them than for others.
The Role of Masking and the Burden of Overcompensation

Many women with ADHD become exceptionally skilled at masking - the act of hiding symptoms by consciously or unconsciously overcompensating.

Masking strategies include:

Extreme organisation attempts or rigid routines
Perfectionism to hide careless mistakes
Over-preparing for work or social interactions
People-pleasing to avoid criticism or rejection
Mimicking others’ behavioural cues to blend in

While these coping methods may appear functional, they are exhausting. The mental load of masking contributes to chronic stress, burnout, and a heightened risk of anxiety disorders. In clinical settings, these secondary symptoms often overshadow the underlying ADHD, resulting in misdiagnoses such as Generalised Anxiety Disorder, Major Depressive Disorder, or even personality disorders.
Emotional Dysregulation and Rejection Sensitivity

Emotional regulation difficulties are a major - though often overlooked - component of ADHD in adults. Women frequently report:

Low frustration tolerance
Rapid mood shifts
Irritability and emotional overwhelm
Difficulty recovering from perceived failure
Rejection Sensitive Dysphoria (RSD): intense emotional pain triggered by real or perceived criticism, rejection, or disapproval

These experiences may be misinterpreted as emotional volatility rather than symptoms of neurodevelopmental wiring. When unrecognised, they often lead to strained relationships, workplace misunderstandings, and diminished self-esteem.
The Impact of Hormonal Changes Across the Lifespan

Hormonal fluctuations strongly influence ADHD symptoms. Oestrogen, in particular, plays a crucial role in modulating dopamine and norepinephrine - neurotransmitters central to ADHD regulation.

Periods of lower oestrogen can significantly worsen symptoms, including:

Premenstrual phase: increased anxiety, irritability, distractibility
Postpartum period: mood instability, exhaustion, executive dysfunction
Perimenopause and menopause: notable symptom intensification

These hormonal effects often lead women to believe their symptoms are caused purely by emotional or mood-related issues, further delaying appropriate assessment.
Physical Conditions That Can Mimic or Exacerbate ADHD

In New Zealand, good practice guidelines require clinicians to assess for physical contributors before confirming an ADHD diagnosis. Subtle medical issues can amplify ADHD-like symptoms.

Common contributors include:

Thyroid dysfunction (hyper- or hypothyroidism): can mimic inattentiveness, mood instability, and fatigue. Treatment may take three months, after which symptoms may reduce significantly.
Iron deficiency: strongly linked to impaired concentration and fatigue.
Cardiac conditions: require screening before stimulant medications are prescribed.

Psychiatrists, GPs, and Nurse Practitioners typically order a set of blood tests and may request an ECG as part of the assessment process.
Diagnosis Pathways in New Zealand: Challenges and Realities

Access to ADHD assessment and treatment in Aotearoa is highly variable and often frustrating.
Public Sector Limitations

Health New Zealand/Te Whatu Ora offers limited ADHD services for adults. Referrals are frequently declined or placed on long waiting lists, especially for women presenting with inattentive symptoms. Many are assigned low clinical priority, effectively delaying diagnosis for years.

Private Sector Barriers

Private assessments provide faster access but come with challenges:

High cost of assessments
Long waitlists for psychiatrists
Inconsistent clinician experience in adult female ADHD
Assessments by psychologists or counsellors that cannot lead to treatment
Patients often paying twice because treatment providers require their own assessment

Who Can Diagnose and Treat ADHD?

Psychiatrists (assessment + treatment)
Paediatricians (children and adolescents)
Mental Health Nurse Practitioners (assessment + treatment)
GPs (from 1 Feb 2026) – although many will not offer ADHD assessments due to the 2–2.5 hour time requirement

Assessments by psychologists can help with understanding and documentation, but do not provide access to medication unless supported by a treating prescriber.
The Diagnostic Process

A comprehensive ADHD assessment must demonstrate:

Symptoms present before age 12
Lifelong patterns across multiple environments
Evidence of functional impairment (work, home, education, relationships)
Exclusion of alternative explanations (e.g. thyroid conditions, mood disorders, trauma)

Clinicians commonly use structured interviews, collateral history, and validated screening tools such as the Adult Self-Report Scale (ASRS).
Why So Many Women Are Missed

Several systemic and social factors contribute to underdiagnosis:

Girls are socialised to be compliant and quiet, masking symptoms.
ADHD stereotypes focus on male hyperactivity.
Women internalise symptoms rather than externalising them.
Functional overcompensation hides impairment.
Emotional symptoms are often misattributed to mood disorders.
Hormonal influences obscure consistent symptom patterns.
Clinician training historically centres on male paediatric ADHD presentations.

The result is a generation of women who grew up believing their struggles were personal failings rather than neurological differences.
Treatment Options in New Zealand

Effective ADHD treatment is multimodal.
Medication

Stimulants remain first-line treatment and can significantly improve focus, organisation, working memory, and emotional regulation. Access requires a prescribing clinician.
Therapeutic Supports

Cognitive Behavioural Therapy (CBT)
ADHD-specific coaching
Executive functioning training
Workplace or academic accommodations

Community Support

Groups such as ADHD New Zealand provide education, peer support, and advocacy for improved services - especially for adult women.
The Path Forward for Women with ADHD in Aotearoa

Growing awareness is reshaping how we understand ADHD across the lifespan. Recognising the unique challenges that women face - clinically, hormonally, socially, and within the healthcare system - is essential for equitable diagnosis and support.

With accurate assessment and appropriate treatment, women with ADHD can experience profound improvements in wellbeing, relationships, academic performance, and career stability.

The key lies in:

Better clinician training
Public education
Affordable assessment pathways
Increased access to prescribers
Reducing stigma and outdated stereotypes

New Zealand now stands at a pivotal moment to ensure that its wāhine are no longer overlooked and can finally access the support, understanding, and care they deserve.